Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-25 @ 9:16 PM
Study NCT ID:
NCT05982756
Status:
UNKNOWN
Last Update Posted:
2023-08-09
First Post:
2023-07-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
Sponsor:
Zhongnan Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None